Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 5/2013

01.05.2013 | Brief Report

Anti-NMDAR encephalitis: a new, severe and challenging enduring entity

verfasst von: Emma H. C. W. van de Riet, Maite M. Esseveld, Leen Cuypers, Jan N. M. Schieveld

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Two girls, 15- and 17-year old, were consecutively and involuntarily admitted to the local child and adolescent psychiatric hospital with severe first onset psychosis. Due to refractory agitation, ongoing psychosis and insomnia, catatonic features, autonomic instability and the need for one-on-one guidance, the first girl was transferred to the PICU of an academic tertiary hospital and anti-NMDA receptor encephalitis was diagnosed. Given this experience nursing staff suspected, due to similarities in the clinical presentation and course, anti-NMDA receptor encephalitis in the second girl also and this proved to be true. The main clinical features, pharmacological and non-pharmacological treatment strategies and outcomes are presented and discussed. Perhaps, one ought to suspect anti-NMDA receptor encephalitis in every case of severe first onset psychosis with catatonic features.
Literatur
1.
Zurück zum Zitat Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098PubMedCrossRef Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098PubMedCrossRef
2.
Zurück zum Zitat Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70(7):504–511PubMedCrossRef Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70(7):504–511PubMedCrossRef
3.
Zurück zum Zitat Chapman MR, Vause HE (2011) Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 168(3):245–251PubMedCrossRef Chapman MR, Vause HE (2011) Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 168(3):245–251PubMedCrossRef
4.
Zurück zum Zitat Creten C, van der Zwaan S, Blankespoor RJ, Maatkamp A, Nicolai J, van Os J, Schieveld JN (2011) Late onset autism and anti-NMDA-receptor encephalitis. Lancet 378(9785):98PubMedCrossRef Creten C, van der Zwaan S, Blankespoor RJ, Maatkamp A, Nicolai J, van Os J, Schieveld JN (2011) Late onset autism and anti-NMDA-receptor encephalitis. Lancet 378(9785):98PubMedCrossRef
5.
Zurück zum Zitat Verhelst H, Verloo P, Dhondt K, De Paepe B, Menten B, Dalmau J, Van Coster R (2011) Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster. Eur J Paediatr Neurol 15(2):163–166PubMedCrossRef Verhelst H, Verloo P, Dhondt K, De Paepe B, Menten B, Dalmau J, Van Coster R (2011) Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster. Eur J Paediatr Neurol 15(2):163–166PubMedCrossRef
6.
Zurück zum Zitat Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66(1):11–18PubMedCrossRef Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66(1):11–18PubMedCrossRef
7.
Zurück zum Zitat Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 231(1–2):86–91PubMedCrossRef Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 231(1–2):86–91PubMedCrossRef
8.
Zurück zum Zitat Bergeron R, Coyle JT (2012) NAAG, NMDA Receptor and Psychosis. Curr Med Chem 19(9):1360–1364PubMedCrossRef Bergeron R, Coyle JT (2012) NAAG, NMDA Receptor and Psychosis. Curr Med Chem 19(9):1360–1364PubMedCrossRef
9.
Zurück zum Zitat Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Thou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30(17):5866–5875PubMedCrossRef Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Thou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30(17):5866–5875PubMedCrossRef
10.
Zurück zum Zitat Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, Coles AJ, Vincent A, Lennox BR (2011) Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 258(4):686–688PubMedCrossRef Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, Coles AJ, Vincent A, Lennox BR (2011) Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 258(4):686–688PubMedCrossRef
11.
Zurück zum Zitat Rhoads J, Guirgis H, McKnight C, Duchemin AM (2011) Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophr Res 129(2–3):213–214PubMedCrossRef Rhoads J, Guirgis H, McKnight C, Duchemin AM (2011) Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophr Res 129(2–3):213–214PubMedCrossRef
Metadaten
Titel
Anti-NMDAR encephalitis: a new, severe and challenging enduring entity
verfasst von
Emma H. C. W. van de Riet
Maite M. Esseveld
Leen Cuypers
Jan N. M. Schieveld
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 5/2013
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-012-0351-0

Weitere Artikel der Ausgabe 5/2013

European Child & Adolescent Psychiatry 5/2013 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.